Skip to main content

Table 1 Gene expression changes induced by ethosuximide in all microarray experiments

From: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression

  1. Selected criteria for inclusion were a FDR corrected p-value less than 0.01 and a calculated mean fold-change (FC) in expression greater than 2 or less than -2 in all four strains analysed. Red shading indicates up-regulated genes; green shading indicates down-regulated genes